5-氯-2-甲酰基苯硼酸 | 870238-36-1

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物 - 环羧酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-氯-2-甲酰基苯硼酸
• 中文别名: 5-氯-2-醛基苯硼酸
• 英文名称: (5-chloro-2-formylphenyl)boronic acid
• 英文别名: 5-chloro-2-formylbenzene boronic acid；(2-formyl-5-chlorophenyl)boronic acid；5-Chloro-2-formylphenylboronic acid
• CAS: 870238-36-1
• 化学式: C₇H₆BClO₃
• mdl: MFCD03425955
• 分子量: 184.387
• InChiKey: LVNPJTSTUBPCMK-UHFFFAOYSA-N

物化性质

• 沸点：
  393.8±52.0 °C(Predicted)
• 密度：
  1.40±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.83
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2931900090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  存储条件为2-8°C，并需保存在惰性气体中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Chloro-2-formylphenylboronic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Chloro-2-formylphenylboronic acid
CAS number: 870238-36-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H6BClO3
Molecular weight: 184.4

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

用途

5-氯-2-甲酰基苯硼酸是一种羧酸类衍生物，主要用于制备电子缓冲材料或电子传输材料。

制备

5-氯-2-甲酰基苯硼酸可通过将5-氯-2-甲基苯硼酸氧化得到。

反应信息

• 作为反应物：
  描述：

  5-氯-2-甲酰基苯硼酸 在 bis-triphenylphosphine-palladium(II) chloride 、 水 、 potassium carbonate 、 caesium carbonate 、 lithium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 乙二醇二甲醚 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 生成 2-chloro-13-cyclohexyl-10-[(2-methylpropan-2-yl)oxycarbonyl]-7H-indolo[2,1-a][2]benzazepine-6-carboxylic acid
  参考文献：
  名称：

  Finger loop inhibitors of the HCV NS5b polymerase. Part II. Optimization of tetracyclic indole-based macrocycle leading to the discovery of TMC647055

  摘要：

  Optimization of a novel series of macrocyclic indole-based inhibitors of the HCV NS5b polymerase targeting the finger loop domain led to the discovery of lead compounds exhibiting improved potency in cellular assays and superior pharmacokinetic profile. Further lead optimization performed on the most promising unsaturated-bridged subseries provided the clinical candidate 27-cyclohexyl-12,13,16,17-tetrahydro-22-methoxy-11,17-dimethyl-10,10-dioxide-2,19-methano-3,7: 4,1-dimetheno-1H, 11H-14,10,2,9,11,17-benzoxathiatetraazacyclo docosine-8,18(9H, 15H)-dione, TMC647055 (compound 18a). This non-zwitterionic 17-membered ring macrocycle combines nanomolar cellular potency (EC50 of 82 nM) with minimal associated cell toxicity (CC50 >20 mu M) and promising pharmacokinetic profiles in rats and dogs. TMC647055 is currently being evaluated in the clinic. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.04.113
• 作为产物：
  描述：

  2-溴-4-氯苯甲醛 在 (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride 、 sodium periodate 、 potassium acetate 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 水 为溶剂， 反应 10.33h， 生成 5-氯-2-甲酰基苯硼酸
  参考文献：
  名称：

  3-(α-丙烯酸)苯并氧杂硼杂环化合物的设计和对映选择性合成以对抗碳青霉烯酶耐药性

  摘要：

  手性 3-取代苯并氧硼杂环被设计为碳青霉烯酶抑制剂，并通过不对称 Morita-Baylis-Hillman 反应有效合成。一些苯并氧杂硼杂环戊烯是临床相关碳青霉烯酶的有效抑制剂，并恢复含有这些酶的细菌中美罗培南的活性。晶体学分析验证了所提出的与碳青霉烯酶结合的机制，即以与其抗生素底物相关的方式。结果说明了基于结构的设计方法与不对称催化相结合如何有效地产生有效的β-内酰胺酶抑制剂，并为开发对抗碳青霉烯酶的药物提供了起点。

  DOI：

  10.1039/d1cc03026d

文献信息

• Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors
  作者：Horrick Sharma、Tino W. Sanchez、Nouri Neamati、Mervi Detorio、Raymond F. Schinazi、Xiaolin Cheng、John K. Buolamwini

  DOI：10.1016/j.bmcl.2013.09.009

  日期：2013.11

  In the present study we report the synthesis of halogen-substituted phenanthrene β-diketo acids as new HIV-1 integrase inhibitors. The target phenanthrenes were obtained using both standard thermal- and microwave-assisted synthesis. 4-(6-Chlorophenanthren-2-yl)-2,4-dioxobutanoic acid (18) was the most active compound of the series, inhibiting both 3′-end processing (3′-P) and strand transfer (ST) with

  在本研究中，我们报告合成卤素取代的菲 β-二酮酸作为新的 HIV-1 整合酶抑制剂。目标菲是使用标准的热和微波辅助合成获得的。4-(6-Chlorophenanthren-2-yl)-2,4-dioxobutanoic acid ( 18 ) 是该系列中活性最强的化合物，可抑制 3'-末端加工 (3'-P) 和链转移 (ST)集成电路50值分别为 5 和 1.3 μM。对接研究揭示了两种主要的结合模式，它们不同于拉替拉韦和艾维替拉韦的结合模式，并表明 IN 活性位点中有一个新的结合区域。此外，预计这些化合物不会与一些与病毒抗性有关的关键氨基酸（Q148 和 N155）发生显着相互作用。因此，可以进一步研究这一系列化合物的可能化学型，以规避对临床 HIV-1 IN 抑制剂的耐药性。
• [EN] BORON CONTAINING COMPOUNDS AND THEIR USES<br/>[FR] COMPOSÉS CONTENANT DU BORE ET LEURS UTILISATIONS
  申请人：BORAGEN INC

  公开号：WO2020264581A1

  公开（公告）日：2020-12-30

  The present disclosure contemplates a boron-containing compound, a composition containing a pesticidal effective amount of that compound dissolved or dispersed in a carrier medium, and a method of reducing, ameliorating, or controlling an infestation by a pest, particularly a fungus, by administering a contemplated composition to a plant or animal in need.

  本公开涉及一种含硼化合物，其中包含该化合物的杀虫有效量溶解或分散在载体介质中的组合物，以及通过向需要的植物或动物施用所述组合物来减少、改善或控制害虫，特别是真菌侵害的方法。
• A new synthetic approach to 6-unsubstituted phenanthridine and phenanthridine-like compounds under mild and metal-free conditions
  作者：Jumreang Tummatorn、Suppachai Krajangsri、Krissada Norseeda、Charnsak Thongsornkleeb、Somsak Ruchirawat

  DOI：10.1039/c4ob00797b

  日期：——

  A new and mild synthetic approach for the synthesis of 6-unsubstituted phenanthridine and phenanthridine-like compounds under metal-free conditions at room temperature has been developed. The strategy involved a tandem azide rearrangement/intramolecular annulation and oxidation reactions of biarylmethyl azide precursors to obtain the desired products in up to 99% yields with high regioselectivity.

  在室温下于无金属条件下，开发了一种用于合成6-未取代菲啶及其类似化合物的新型温和合成方法。该策略涉及二芳基甲基叠氮前体的串联叠氮重排/分子内环化及氧化反应，以高达99%的产率和高区域选择性获得目标产物。
• NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS
  申请人：Kolasa Teodozyj

  公开号：US20080242654A1

  公开（公告）日：2008-10-02

  The present application relates to thiazolylidene containing compounds of formula (I) wherein R 1 , R 2 , R 3 , R 4 , L 2 and A are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.

  本申请涉及具有以下式（I）的含噻唑基烯醇化合物，其中R1、R2、R3、R4、L2和A如规范中所定义。还公开了包含这种化合物的组合物，以及使用这种化合物和组合物治疗疾病和疾病的方法。
• PICOLINAMIDO-PROPANOIC ACID DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS
  申请人：Chakravarty Devraj

  公开号：US20120302610A1

  公开（公告）日：2012-11-29

  The present invention is directed to picolanmido-propanoic acid derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.

  本发明涉及吡咯烷酰基丙酸衍生物，含有它们的药物组合物以及它们在治疗和/或预防通过拮抗一个或多个胰高血糖素受体而改善的疾病和症状中的用途，包括例如代谢性疾病，如2型糖尿病和肥胖症。